Imaging study of semaglutide for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study uses special MRI scans to see how the diabetes medication semaglutide affects muscles and fat. If you are starting semaglutide for type 2 diabetes, this research may help doctors understand how the medicine works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old.
- You have type 2 diabetes with an HbA1c level between 7% and 10.5%.
- You are about to start semaglutide (a once-weekly injectable diabetes medicine)
- Your body mass index (BMI) is between 30 and 45.
- You are willing to have an MRI scan.
- You have not had a heart attack, heart failure hospitalization, or major surgery in the past 30 days.
- You are not currently using other weight-loss medications (like phentermine or contrave) or steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how certain diabetes medications affect the body's makeup (like muscle and fat) and how the body works, using special imaging scans. It may help doctors understand these treatments better and could guide future care.
This study looks at how semaglutide (Ozempic or Wegovy) changes heart muscle and body muscle. It may help people with type 2 diabetes or those taking the drug for weight loss understand if their heart is affected.
This trial tests whether semaglutide changes blood flow in the brain and the brain’s “barrier” (how well the brain is protected) in people with type 2 diabetes. It may help researchers understand brain-related effects of diabetes treatment using scans and blood tests.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study uses a special type of MRI to look at how your heart and brain use energy, in people with type 2 diabetes. It aims to understand the effects of a common diabetes drug called semaglutide, which could help guide better treatment.
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.